September 28, 2015

FDA Clears ArtVentive's 11-mm EOS Device

September 29, 2015—ArtVentive Medical Group, Inc. announced that it has received US Food and Drug Administration clearance for its 11-mm EOS (endoluminal occlusion system). The EOS device is designed for use in the peripheral vasculature to provide immediate and complete vessel occlusion in arterial and venous settings.

According to the company, EOS is a catheter-based, self-expandable device that facilitates permanent and immediate occlusion of peripheral vessels. EOS is designed to serve as a safe and reliable alternative to major surgery in certain cases. With the new clearance, the device is approved to treat vessels from 3 to 11 mm in diameter, the company stated.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

September 28, 2015

FDA Clears ArtVentive's 11-mm EOS Device

Current Issue

Keep In Touch